Sign In
Buy LGND
$287.54
-8.75 (-2.95%)
At Close: Jul 31, 2026
LGND or ILMN: Which Is the Better Value Stock Right Now?
12:45pm, Tuesday, 06'th Jun 2023
Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Ligand Pharmaceuticals (LGND) and Illumina (ILMN). But which of these two companies is the best opti
Novartis Announces Positive Data on Breast Cancer Drug Kisqali
03:56pm, Monday, 05'th Jun 2023
Novartis' (NVS) Kisqali reduces the risk of recurrence by 25% among patients with early breast cancer.
3 Stocks That Smart Investors Should Be Flocking to Now
07:01pm, Tuesday, 30'th May 2023
Although investors can bag profits by following the masses, it's also possible to accrue substantive rewards by walking the path least traveled with top stocks for smart investors. That's not to say t
Wall Street Analysts Think Ligand (LGND) Could Surge 44.42%: Read This Before Placing a Bet
10:57am, Wednesday, 24'th May 2023
The mean of analysts' price targets for Ligand (LGND) points to a 44.4% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Load Up on These 5 Exceptional Relative Price Strength Stocks
08:24am, Tuesday, 16'th May 2023
IDCC, TMHC, NXT, GRBK and LGND are five stocks with explosive relative price strength.
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings
01:43pm, Monday, 08'th May 2023
Ligand Pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management raises 2023 financial outlook.
Wall Street Analysts Believe Ligand (LGND) Could Rally 38.66%: Here's is How to Trade
11:26am, Monday, 08'th May 2023
The mean of analysts' price targets for Ligand (LGND) points to a 38.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
New Strong Buy Stocks for May 5th
08:23am, Friday, 05'th May 2023
VREX, LGND, RNGR, SIGA and KMT have been added to the Zacks Rank #1 (Strong Buy) List on May 5, 2023.
Ligand Pharmaceuticals Incorporated (LGND) Q1 2023 Earnings Call Transcript
10:49pm, Thursday, 04'th May 2023
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND ) Q1 2023 Results Conference Call May 4, 2023 4:30 PM ET Company Participants Simon Latimer - Head of Investor Relations Todd Davis - Chief Executive O
Ligand Pharmaceuticals (LGND) Surpasses Q1 Earnings and Revenue Estimates
07:01pm, Thursday, 04'th May 2023
Ligand Pharmaceuticals (LGND) came out with quarterly earnings of $2.28 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $0.58 per share a year ago.
2 Medical Stocks to Buy Before Earnings
10:12pm, Tuesday, 02'nd May 2023
Cardinal Health (CAH) and Ligand Pharmaceuticals (LGND) are two healthcare companies that investors certainly want to watch going into their quarterly reports.
LGND vs. REGN: Which Stock Is the Better Value Option?
12:57pm, Tuesday, 02'nd May 2023
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Ligand Pharmaceuticals (LGND) and Regeneron (REGN). But which of these two stocks presents investors with the
KALA Up on Fast Track Designation to Lead Ocular Candidate
12:56pm, Thursday, 13'th Apr 2023
KALA gets Fast Track Designation from the FDA for lead candidate KPI-012 to treat persistent corneal epithelial defects.
Wall Street Analysts Predict a 53.67% Upside in Ligand (LGND): Here's What You Should Know
11:24am, Tuesday, 04'th Apr 2023
The mean of analysts' price targets for Ligand (LGND) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Ligand Pharmaceuticals: Expanding Royalty Portfolio And Strong Drug Pipeline
10:30am, Saturday, 25'th Mar 2023
Ligand's strategy of providing development capital to high-quality assets with capable teams is paying off, as evidenced by the recent positive developments and advancements in its product pipeline. L
